These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3722946)

  • 1. [Study on the maintenance of the accuracy of cytological diagnosis in the mass screening of uterine cervical cancer].
    Takahashi K; Yamane Y; Fukuda S; Kijima S; Moriyama M; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):633-7. PubMed ID: 3722946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of screening, detection and mortality rates in mass screening for uterine cervical cancer in Shimane prefecture].
    Takahashi K; Moriyama M; Takamiya O; Shibukawa T; Iwanari O; Matsunaga I; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):377-82. PubMed ID: 3981047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of mass screening by automobile for cancer of the cervix uteri in Fukui Prefecture in the past ten years].
    Iida K; Hirai T; Tominaga T; Tsuda T; Matsuda S; Yamada M; Tsuchida H; Takeuchi K; Ootsuki Y; Oomori M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2171-7. PubMed ID: 3805827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A result of mass-screening for uterine cervical cancer in Hyogo prefecture (author's transl)].
    Hasegawa K; Miyazaki Y; Kitaura Y; Ohtsu F; Takeuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2097-104. PubMed ID: 7338662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Developments in mass screening for uterine cancer in the past 10 years (1972-1981) in Shimane Prefecture--cell sampling method and the central cytological diagnostic system].
    Iwanari O; Matsunaga I; Moriyama M; Takahashi K; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jul; 36(7):1008-16. PubMed ID: 6747385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of cytologic mass screening in the Federal Republic of Germany.
    Soost HJ; Bockmühl B; Zock H
    Acta Cytol; 1982; 26(4):445-52. PubMed ID: 6957096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of mass screening for cervical cancer in Shiga Prefecture].
    Ishiguro T; Yoshida Y; Tenzaki T; Tanaka B
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):655-60. PubMed ID: 6864024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on a cell sampling method in mass screening for uterine cervical cancer--comparison of data obtained with a cotton tipped applicator, wooden spatula and cotton tipped applicator plus colposcopy].
    Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Yamamoto K; Iwanari O; Matsunaga I; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1117-24. PubMed ID: 4031569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
    Arbyn M; Schenck U; Ellison E; Hanselaar A
    Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appraisal of self-collected cervical specimens in cytologic screening of uterine cancer.
    Arata T; Sekiba K; Kato K
    Acta Cytol; 1978; 22(3):150-2. PubMed ID: 277040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [False negative Pap smears in a Danish material].
    Ejersbo D; Dahl MB; Hølund B
    Ugeskr Laeger; 2003 Jun; 165(23):2391-4. PubMed ID: 12840998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the adequacy of Pap smears.
    Baker RM
    Am Fam Physician; 1989 Jun; 39(6):109-14. PubMed ID: 2729036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate frequency of mass-screening for uterine cervical cancer.
    Iwanari O
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1799-805. PubMed ID: 3429977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low proportion of false-negative smears in the Finnish program for cervical cancer screening.
    Lönnberg S; Anttila A; Kotaniemi-Talonen L; Kujari H; Melkko J; Granroth G; Vornanen M; Pietiläinen T; Sankila A; Arola J; Luostarinen T; Nieminen P
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):381-7. PubMed ID: 20142239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.